Mrs. Kathrin Schön, CSL Behring Innovation GmbH, Marburg, Germany, Germany
Profile
Orcid
Summary 📋
Dr. Kathrin Schön is a dedicated medical professional specializing in human genetics. With extensive experience in genetic counseling, molecular genetics, and cytogenetic analysis, she combines her clinical expertise with a robust research background in pharmacology and toxicology.
Education 🎓
Medicine (10/2013 – 11/2021), Philipps University Marburg
Licence to practise medicine on December 08, 2021
MD Thesis (03/2018 – ongoing), CSL Behring Innovation GmbH, Marburg
“Characterization of rFIX fusion proteins enabling subcutaneous administration”
Professional Experience 🏥
Physician in Human Genetics (since 07/2023), IMD Humangenetik Wiesbaden
Genetic counseling, examination, molecular genetic analysis, and cytogenetic laboratory work
Medical Affairs Trainee (10/2022 – 04/2023), Dr. Reiner Rittinghausen GmbH
Account management and sales
Physician (01/2022 – 08/2022), Local Health Department′s Coronavirus Faculty, Marburg
Consultant (01/2020 – ongoing), Clinical Development, CSL Behring Innovation GmbH
MD Thesis Doctoral Student (03/2018 – ongoing), CSL Behring Innovation GmbH, Marburg
Research Interests 🔬
Human Genetics: Genetic counseling and molecular genetic analysis
Pharmacology & Toxicology: Characterization of recombinant Factor IX fusion proteins
Hematology and Oncology: Clinical studies and patient care in hematology and oncology
Publications📚
Characterization of recombinant Factor IX fusion proteins enabling subcutaneous administration
Authors: Kathrin Schön, Sabine Pestel, Julia Riedesel, Waltraud Seyfert-Brandt, Philipp Claar, Eva Herzog, Alireza Rezvani-Sharif, Padmapriya Ponnuswamy, Marc W. Nolte
Journal: Journal of Thrombosis and Haemostasis
Year: 2024
Patient‐physician interactions in hereditary angioedema—Key learnings from the coronavirus disease 2019 pandemic
Authors: Maurer M, Buttgereit T, Magerl M, Schön K, Balla Z, Farkas H
Journal: Clinical and Translational Allergy
Year: 2023
Conference Poster: Characterization of rFIX fusion proteins enabling subcutaneous administration
Authors: Kathrin Schön, J. Riedesel, W. Seyfert-Brandt, S. Pestel, M. Mischnik, W. Azar, W. Hardy, M.W. Nolte, P. Claar
Journal: 65th Annual Meeting of the Society of Thrombosis and Hemostasis Research
Year: 2021